Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT

Abstract Background Novel chemotherapeutic drugs with good anti-tumor activity are of pressing need for bladder cancer treatment. In this study, plumbagin (PL), a natural plant-derived drug extracted from Chinese herbals, was identified as a promising candidate for human bladder cancer (BCa) chemoth...

Full description

Bibliographic Details
Main Authors: Renjie Zhang, Zijian Wang, Wenjie You, Fengfang Zhou, Zicheng Guo, Kaiyu Qian, Yu Xiao, Xinghuan Wang
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Cancer Cell International
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12935-020-01607-y
_version_ 1818316533078687744
author Renjie Zhang
Zijian Wang
Wenjie You
Fengfang Zhou
Zicheng Guo
Kaiyu Qian
Yu Xiao
Xinghuan Wang
author_facet Renjie Zhang
Zijian Wang
Wenjie You
Fengfang Zhou
Zicheng Guo
Kaiyu Qian
Yu Xiao
Xinghuan Wang
author_sort Renjie Zhang
collection DOAJ
description Abstract Background Novel chemotherapeutic drugs with good anti-tumor activity are of pressing need for bladder cancer treatment. In this study, plumbagin (PL), a natural plant-derived drug extracted from Chinese herbals, was identified as a promising candidate for human bladder cancer (BCa) chemotherapy. Methods The anti-tumor activity of PL was evaluated using a series of in vitro experiments, such as MTT, transwell assay, flow cytometry, quantitative real-time PCR (qRT-PCR) and western blotting. We established xenograft tumors in nude mice by subcutaneous injection with the human bladder cancer T24 cells. Results The results showed that PL could inhibit the proliferation, migration and survival of BCa cells (T24 and UMUC3 cells) in a time- and dose-dependent way. We found PL promotes the cell cycle arrest and apoptosis by inhibiting PI3K/AKT/mTOR signaling pathway, which inhibits cell proliferation. In vivo, anti-tumor activity of PL was further investigated using a BCa cell xenograft mice model. To simulate clinical chemotherapy, the PL were intravenously injected with a dose of 10 mg/kg for 10 times. Compared with the blank control, the tumor weight in PL treated group decreased significantly from 0.57 ± 0.04 g to 0.21 ± 0.06 g (P < 0.001). Conclusions In our study. We found PL inhibits the proliferation of T24 and UMUC3 cells in vivo and in vitro, which may play a role through several downstream effectors of PI3K/AKT/mTOR signaling pathway to promote the cell cycle arrest and apoptosis. Meanwhile, we consider that PL may inhibit the migration of bladder cancer cells via EMT suppression and induce ROS generation to make cell apoptosis. This work screened out a novel chemotherapeutic drug (plumbagin) with relatively good anti-tumor activity, which possessed great potential in BCa chemotherapy.
first_indexed 2024-12-13T09:22:56Z
format Article
id doaj.art-add6473cc0de414a82915196df91ff12
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-12-13T09:22:56Z
publishDate 2020-10-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-add6473cc0de414a82915196df91ff122022-12-21T23:52:42ZengBMCCancer Cell International1475-28672020-10-0120111710.1186/s12935-020-01607-ySuppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMTRenjie Zhang0Zijian Wang1Wenjie You2Fengfang Zhou3Zicheng Guo4Kaiyu Qian5Yu Xiao6Xinghuan Wang7Department of Urology, Zhongnan Hospital of Wuhan UniversityDepartment of Urology, Zhongnan Hospital of Wuhan UniversityDepartment of Urology, Zhongnan Hospital of Wuhan UniversityDepartment of Urology, Zhongnan Hospital of Wuhan UniversityDepartment of Urology, The Central Hospital of Enshi Tujia and Miao Autonomous PrefectureDepartment of Urology, Zhongnan Hospital of Wuhan UniversityDepartment of Biological Repositories, Zhongnan Hospital of Wuhan UniversityDepartment of Urology, Zhongnan Hospital of Wuhan UniversityAbstract Background Novel chemotherapeutic drugs with good anti-tumor activity are of pressing need for bladder cancer treatment. In this study, plumbagin (PL), a natural plant-derived drug extracted from Chinese herbals, was identified as a promising candidate for human bladder cancer (BCa) chemotherapy. Methods The anti-tumor activity of PL was evaluated using a series of in vitro experiments, such as MTT, transwell assay, flow cytometry, quantitative real-time PCR (qRT-PCR) and western blotting. We established xenograft tumors in nude mice by subcutaneous injection with the human bladder cancer T24 cells. Results The results showed that PL could inhibit the proliferation, migration and survival of BCa cells (T24 and UMUC3 cells) in a time- and dose-dependent way. We found PL promotes the cell cycle arrest and apoptosis by inhibiting PI3K/AKT/mTOR signaling pathway, which inhibits cell proliferation. In vivo, anti-tumor activity of PL was further investigated using a BCa cell xenograft mice model. To simulate clinical chemotherapy, the PL were intravenously injected with a dose of 10 mg/kg for 10 times. Compared with the blank control, the tumor weight in PL treated group decreased significantly from 0.57 ± 0.04 g to 0.21 ± 0.06 g (P < 0.001). Conclusions In our study. We found PL inhibits the proliferation of T24 and UMUC3 cells in vivo and in vitro, which may play a role through several downstream effectors of PI3K/AKT/mTOR signaling pathway to promote the cell cycle arrest and apoptosis. Meanwhile, we consider that PL may inhibit the migration of bladder cancer cells via EMT suppression and induce ROS generation to make cell apoptosis. This work screened out a novel chemotherapeutic drug (plumbagin) with relatively good anti-tumor activity, which possessed great potential in BCa chemotherapy.http://link.springer.com/article/10.1186/s12935-020-01607-yPlumbaginBladder cancerPI3K/AKT/mTORCell cycleApoptosis
spellingShingle Renjie Zhang
Zijian Wang
Wenjie You
Fengfang Zhou
Zicheng Guo
Kaiyu Qian
Yu Xiao
Xinghuan Wang
Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT
Cancer Cell International
Plumbagin
Bladder cancer
PI3K/AKT/mTOR
Cell cycle
Apoptosis
title Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT
title_full Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT
title_fullStr Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT
title_full_unstemmed Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT
title_short Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT
title_sort suppressive effects of plumbagin on the growth of human bladder cancer cells via pi3k akt mtor signaling pathways and emt
topic Plumbagin
Bladder cancer
PI3K/AKT/mTOR
Cell cycle
Apoptosis
url http://link.springer.com/article/10.1186/s12935-020-01607-y
work_keys_str_mv AT renjiezhang suppressiveeffectsofplumbaginonthegrowthofhumanbladdercancercellsviapi3kaktmtorsignalingpathwaysandemt
AT zijianwang suppressiveeffectsofplumbaginonthegrowthofhumanbladdercancercellsviapi3kaktmtorsignalingpathwaysandemt
AT wenjieyou suppressiveeffectsofplumbaginonthegrowthofhumanbladdercancercellsviapi3kaktmtorsignalingpathwaysandemt
AT fengfangzhou suppressiveeffectsofplumbaginonthegrowthofhumanbladdercancercellsviapi3kaktmtorsignalingpathwaysandemt
AT zichengguo suppressiveeffectsofplumbaginonthegrowthofhumanbladdercancercellsviapi3kaktmtorsignalingpathwaysandemt
AT kaiyuqian suppressiveeffectsofplumbaginonthegrowthofhumanbladdercancercellsviapi3kaktmtorsignalingpathwaysandemt
AT yuxiao suppressiveeffectsofplumbaginonthegrowthofhumanbladdercancercellsviapi3kaktmtorsignalingpathwaysandemt
AT xinghuanwang suppressiveeffectsofplumbaginonthegrowthofhumanbladdercancercellsviapi3kaktmtorsignalingpathwaysandemt